Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patients
Hyo Jin Kim, Ju-Yeon Cho, Yu Jin Kim, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo, Joon Hyeok Lee
Korean J Intern Med. 2015;30(1):32-41. Published online 2014 Dec 30 DOI: https://doi.org/10.3904/kjim.2015.30.1.32
Citations to this article as recorded by 
Clinical effects of combined treatment of traditional Chinese medicine and western medicine for viral hepatitis B cirrhosis and the effects on serum miR-122, miR-200a
Xiaofan You, Fen Jiang, Yiliang Zhang
Biotechnology and Genetic Engineering Reviews.2023; : 1. CrossRef
Tenofovir disoproxil fumarate for multiple nucleos(t)ide analogues treatment failure hepatitis B: Is monotherapy enough?
Xieer Liang, Qing Xie, Jia Shang, Hong Tang, Min Xu, Qinghua Meng, Jiming Zhang, Pujun Gao, Jifang Sheng, Hao Wang, Jidong Jia, Guiqiang Wang, Shunquan Wu, Jingna Ping, Jinlin Hou
Journal of Gastroenterology and Hepatology.2022; 37(3): 471. CrossRef
Guidelines for Prevention and Treatment of Chronic Hepatitis B
Guiqiang Wang, Zhongping Duan
Journal of Clinical and Translational Hepatology.2021; 000(000): 000. CrossRef
Tenofovir disoproxil fumarate for patients with chronic hepatitis B who suboptimal response to non‐tenofovir disoproxil fumarate nucleos(t)ide analogs therapy
Kwei‐Ming Chen, Chi‐Hsien Chang, Jyong‐Hong Lee, Chi‐Chieh Yang
Advances in Digestive Medicine.2020; 7(4): 207. CrossRef
Adverse events of nucleos(t)ide analogues for chronic hepatitis B: a systematic review
Raquel Scherer de Fraga, Victor Van Vaisberg, Luiz Cláudio Alfaia Mendes, Flair José Carrilho, Suzane Kioko Ono
Journal of Gastroenterology.2020; 55(5): 496. CrossRef
Tenofovir‐based combination therapy or monotherapy for multidrug‐resistant chronic hepatitis B: Long‐term data from a multicenter cohort study
Hyung Joon Yim, Sang Jun Suh, Young Kul Jung, Seong Gyu Hwang, Yeon Seok Seo, Soon Ho Um, Sae Hwan Lee, Young Seok Kim, Jae Young Jang, In Hee Kim, Hyoung Su Kim, Ji Hoon Kim, Young Sun Lee, Eileen L. Yoon, Myeong Jun Song, Jun Yong Park
Journal of Viral Hepatitis.2020; 27(12): 1306. CrossRef
Risk factors associated with hypophosphatemia in chronic Hepatitis B patients treated with tenofovir disoproxil fumarate
Dohyeong Lee, Byung Cheol Yun, Kwang Il Seo, Byung Hoon Han, Sang Uk Lee, Eun Taek Park, Jin Wook Lee, Joonho Jeong
Medicine.2019; 98(50): e18351. CrossRef
Real World Experience of Telbivudine Versus Entecavir in Patients with Chronic Hepatitis B, Including Long-Term Outcomes after Treatment Modification
Jong Won Choi, Se Hyun Kim, Jeong Hun Seo, Yong Suk Cho, Sun Young Won, Byung Kyu Park, Han Ho Jeon, Yong Kang Lee, Chun Kyon Lee
Yonsei Medical Journal.2018; 59(3): 383. CrossRef
Treatment Efficacy and Safety of Tenofovir-Based Therapy in Chronic Hepatitis B: A Real Life Cohort Study in Korea
Hyo Jun Ahn, Myeong Jun Song, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Haitao Guo
PLOS ONE.2017; 12(1): e0170362. CrossRef
Management of Clevudine-Resistant Chronic Hepatitis B: A Multicenter Cohort Study
Eun Young Cho, Hyung Joon Yim, Young Kul Jung, Sang Jun Suh, Yeon Seok Seo, Ji Hoon Kim, Hong Soo Kim, Sae Hwan Lee, Sang Hoon Ahn, Jeong Il Lee, Sook-Hyang Jeong, Jin-Wook Kim, Jin-Woo Lee, In Hee Kim, Hyoung Su Kim, Sang Jong Park, Jeong Mi Lee, Seong G
Gut and Liver.2017; 11(1): 129. CrossRef
Efficacy and Safety of Tenofovir Disoproxil Treatment for Chronic Hepatitis B Patients with Genotypic Resistance to Other Nucleoside Analogues
Jing Zhou, Yue-Ying Liu, Jiang-Shan Lian, Li-Fang Pan, Jian-Le Yang, Jian-Rong Huang
Chinese Medical Journal.2017; 130(8): 914. CrossRef
The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy
Jeong Han Kim, Sung Hyun Ahn, Soon Young Ko, Won Hyeok Choe, Kyun-Hwan Kim, So Young Kwon
Clinical and Molecular Hepatology.2016; 22(2): 241. CrossRef
Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B?
Hyung Joon Yim
Clinical and Molecular Hepatology.2016; 22(2): 238. CrossRef
Antiviral Therapy in Lamivudine-Resistant Chronic Hepatitis B Patients: A Systematic Review and Network Meta-Analysis
Hui-Lian Wang, Xi Lu, Xudong Yang, Nan Xu
Gastroenterology Research and Practice.2016; 2016: 1. CrossRef
UPLC–MS/MS method for the simultaneous quantification of anti-HBV nucleos(t)ides analogs: Entecavir, lamivudine, telbivudine and tenofovir in plasma of HBV infected patients
Amedeo De Nicolò, Marco Simiele, Debora Pensi, Lucio Boglione, Sarah Allegra, Giovanni Di Perri, Antonio D’Avolio
Journal of Pharmaceutical and Biomedical Analysis.2015; 114: 127. CrossRef
Is tenofovir disoproxil fumarate an all-powerful weapon in the treatment of chronic hepatitis B?
Ji Hoon Kim, June Sung Lee
The Korean Journal of Internal Medicine.2015; 30(1): 23. CrossRef
Tenofovir disoproxil fumarate
Reactions Weekly.2015; 1555(1): 186. CrossRef